MONTANA CANCER CONSORTIUM

Montana Cancer Consortium (MCC) is an independent not-for-profit organization. MCC receives funding through the National Cancer Institute (NCI) Community Oncology Research Program (NCORP) grant mechanism. MCC serves the entire state of Montana and northern Wyoming and northern Idaho. Montana Cancer Consortium inception in 1996 was prompted by a need in this vast rural area to unify medical and radiation oncologists to cooperate in bringing state-of-the-art cancer treatment to a population with little access to clinical trials. While individual physician groups were working through various mechanisms to accrue to NCI-sponsored clinical trials, there was no direct, unified effort to make a number of clinical trials available to the majority of this rural population. MCC establishes the unique opportunity for clinical trial participation for all of the service area’s oncology providers. MCC has more than 100 ongoing clinical trials. MCC physicians have entered more than 4000 patients to treatment, cancer control, and prevention clinical trials. MCC physician members includes medical oncologists, radiation oncologists and surgeons in the states of Montana, Idaho, and Wyoming.